Improved Bevirimat resistance prediction by combination of structural and sequence-based classifiers
2011
Background
Maturation inhibitors such as Bevirimat are a new class of antiretroviral drugs that hamper the cleavage of HIV-1 proteins into their functional active forms. They bind to these preproteins and inhibit their cleavage by the HIV-1 protease, resulting in non-functional virus particles. Nevertheless, there exist mutations in this region leading to resistance against Bevirimat. Highly specific and accurate tools to predict resistance to maturation inhibitors can help to identify patients, who might benefit from the usage of these new drugs.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
46
References
19
Citations
NaN
KQI